Abstract:Apoptosis, a natural process of programmed cell death, is a promising therapeutic target as the disruption of apoptosis evolves in many diseases including cancer. Several pieces of evidence indicate that errors in apoptotic pathways result in the imbalance between cell proliferation and death, allowing cells with genetic abnormalities to survive. The intrinsic and extrinsic pathways of apoptosis utilize different caspases to execute the event of cell death through the cleavage of hundreds of proteins. Proteins from the Bcl-2 family, a pivotal component of the mitochondrial apoptosis pathway, activate the death signal either directly or indirectly involving mitochondrial translocation of Bax/Bak, which are recognized critical elements in defective apoptosis. The majority of chemotherapeutic drugs destroy cancer cells by activating the apoptotic machinery via Bcl-2/Bax-dependent process and failure of which leads to an intrinsic chemoresistance. Recent insights into the dynamic action of pro-survival Bcl-2 proteins in cancer pathogenesis and resistance has set the stage for the development of small molecules as Bcl-2 antagonist and modulators of apoptosis. The BH3-only proteins are vital inducers of the mitochondrial apoptosis mechanism that operate either by assuming the functional activity of the proapoptotic Bcl-2 family members or by impeding the antiapoptotic Bcl-2 proteins. Based on the structural interaction studies between the proapoptotic and anti-apoptotic proteins, several synthetic peptides have been designed to functionally mimic the BH3 domain, targeting directly the pro-survival Bcl-2 proteins. The "BH3-peptide mimetics" a novel class of Bcl-2 protein antagonists essentially play an important role in the treatment of malignancies as they are predicted to persuade non-receptor mediated programmed cell death. This review summarizes the most promising BH3-peptide mimetic compounds that function as selective antagonists of Bcl-2 proteins and would be effective in treating various cancers.

Research of Synthetic Small Mimic-Peptide on Apoptosis of Prostate Cancer Cells

[Anti-Prostate Cancer Activity of Survivin-T34A Mutant in Vitro and in Vivo].

Capilliposide C Derived from Lysimachia Capillipes Hemsl Inhibits Growth of Human Prostate Cancer PC3 Cells by Targeting Caspase and MAPK Pathways.

Synthetic small peptides acting on B7H1 enhance apoptosis in pancreatic cancer cells.

Inhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitro

A Novel Class of Peptides That Induce Apoptosis and Abrogate Tumorigenesisin Vivo

Expression of PED/PEA-15 and XIAP in prostate cancer cells and their effects on prostate cancer cell (PC-3) apoptosis

The Novel Small Molecular BH3 Mimetics SM3 and Its Regulation of Cell Apoptosis and Autophagy.

Two novel peptides derived from Sinonovacula constricta inhibit the proliferation and induce apoptosis of human prostate cancer cells

Synthesis and Biological Evaluation of N-Phosphoryl Dipeptide Derivatives As Potent Apoptosis Inducers

BH3 Mimetic Peptides: An Effective Strategy to Complement Anticancer Therapy

Peptide-conjugated Nanoparticles for Targeted Imaging and Therapy of Prostate Cancer

Comparative Study of the Potential Cell-Penetrating Peptide ∆M4 on Apoptosis Cell Signaling in A375 and A431 Cancer Cell Lines

Design, in silico evaluation, and in vitro verification of new bivalent Smac mimetics with pro-apoptotic activity

Cell Permeable Bcl-2 Binding Peptides: A Chemical Approach to Apoptosis Induction in Tumor Cells

Mechanism of BH3 Mimetics Promoting Cell Apoptosis and Its Latest Clinical Research Progress

Small peptides elicit anti-tumor effects in CT26 model through blocking PD-L1/PD-1 (TUM2P.900)

Targeting Cellular Apoptotic Pathway with Peptides from Marine Organisms

Expression of PED/PEA-15 in Prostate Cancer and Its Effect on Apoptosis of Prostate Cancer Cell

Inhibition of Mitogen-Elicited Signal Transduction and Growth in Prostate Cancer with a Small Peptide Derived from the Functional Domain of DOC-2/DAB2 Delivered by a Unique Vehicle.

Small Interfering RNA Targeting HMGN5 Induces Apoptosis Via Modulation of a Mitochondrial Pathway and Bcl-2 Family Proteins in Prostate Cancer Cells.